Sustained clinical effectiveness of interferon-β-1b in multiple sclerosis patients

被引：0
|
作者：
Shimpi, AV
Layton, B
Bashir, K
机构：
来源：
ANNALS OF NEUROLOGY | 2004年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [1] Interferon-β1b for the treatment of multiple sclerosis
    Lam, Sum
    Wang, Shan
    Gottesman, Malcolm
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2008, 4 (08) : 1111 - 1117
  • [2] Immunomodulatory effects of interferon-β-1b in patients with multiple sclerosis
    Ossege, LM
    Sindern, E
    Patzold, T
    Malin, JP
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2001, 1 (06) : 1085 - 1100
  • [3] Interferon-β1b in the treatment of multiple sclerosis
    Río, J
    Montalban, X
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2877 - 2886
  • [4] Interferon-β-1b -: In newly emerging multiple sclerosis
    McKeage, Kate
    CNS DRUGS, 2008, 22 (09) : 787 - 792
  • [5] Cytokines and adhesion molecules in multiple sclerosis patients treated with interferon-β1b
    Jensen, J
    Krakauer, M
    Sellebjerg, F
    CYTOKINE, 2005, 29 (01) : 24 - 30
  • [6] Interferon-β-1b A Review of its Use in Multiple Sclerosis
    Plosker, Greg L.
    CNS DRUGS, 2011, 25 (01) : 67 - 88
  • [7] Combined treatment of multiple sclerosis patients with cytostatics and interferon-β (1a,1b)
    Daskalovska, V
    Dimova, A
    Bojkovski, V
    Boskova-Petkovska, T
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S262 - S262
  • [8] Differential immunomodulatory effects of interferon-β1a/1b in patients with multiple sclerosis
    Papachroni, K.
    Fragoulis, N.
    Piperi, C.
    Patrikiou, A.
    Papadimitriou, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 142 - 142
  • [9] Apolipoprotein Alleles and the Response to Interferon-β-1b in Multiple Sclerosis
    Carmona, Olga
    Masuet, Cristina
    Alia, Pedro
    Moral, Ester
    Alonso-Magdalena, Lucia
    Casado, Virginia
    Martin-Ozaeta, Gisela
    Arbizu, Txomin
    EUROPEAN NEUROLOGY, 2011, 65 (03) : 132 - 137
  • [10] Neutralizing antibodies in multiple sclerosis patients treated with 375 μg interferon-β-1b
    Durelli, L.
    Barbero, P.
    Cucci, A.
    Ferrero, B.
    Ricci, A.
    Contessa, G.
    De Mercanti, S.
    Ripellino, P.
    Lapuma, D.
    Viglietta, E.
    Bergui, M.
    Versino, E.
    Clerico, M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (04) : 387 - 397
12345